Small packages: UI nanotechnology firm gets $2 million boost in fight against cancer
Eastern Iowa corridor spinoff continues to validate the clinical significance of the novel theranostic.
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa
The funding supplements the NIH Phase II award, in particular commercialization efforts related to establishing a clinical trial network.
UI spin-off NanoMedTrix awarded $2 million from National Cancer Institute.
University of Iowa College of Engineering release The SBIR grant is designed to bring the technology beyond the theoretical phase and closer to clinical trials for the treatment of bladder cancer.